170 related articles for article (PubMed ID: 25310131)
21. FOXM1 is overexpressed in B-acute lymphoblastic leukemia (B-ALL) and its inhibition sensitizes B-ALL cells to chemotherapeutic drugs.
Consolaro F; Basso G; Ghaem-Magami S; Lam EW; Viola G
Int J Oncol; 2015 Oct; 47(4):1230-40. PubMed ID: 26316295
[TBL] [Abstract][Full Text] [Related]
22. Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells.
Lok GT; Chan DW; Liu VW; Hui WW; Leung TH; Yao KM; Ngan HY
PLoS One; 2011; 6(8):e23790. PubMed ID: 21858223
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of forkhead box M1 (FoxM1) expression and antitumour effect of FoxM1 inhibition in melanoma.
Ito T; Kohashi K; Yamada Y; Maekawa A; Kuda M; Furue M; Oda Y
Histopathology; 2016 Jul; 69(1):63-71. PubMed ID: 26619071
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy.
Uddin S; Ahmed M; Hussain A; Abubaker J; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Jehan Z; Bavi P; Siraj AK; Al-Kuraya KS
Am J Pathol; 2011 Feb; 178(2):537-47. PubMed ID: 21281787
[TBL] [Abstract][Full Text] [Related]
25. Identification of FOXM1 as a specific marker for triple‑negative breast cancer.
Tan Y; Wang Q; Xie Y; Qiao X; Zhang S; Wang Y; Yang Y; Zhang B
Int J Oncol; 2019 Jan; 54(1):87-97. PubMed ID: 30365046
[TBL] [Abstract][Full Text] [Related]
26. Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells.
Bhat UG; Halasi M; Gartel AL
PLoS One; 2009; 4(5):e5592. PubMed ID: 19440351
[TBL] [Abstract][Full Text] [Related]
27. FOXM1 and androgen receptor co-regulate CDC6 gene transcription and DNA replication in prostate cancer cells.
Liu Y; Gong Z; Sun L; Li X
Biochim Biophys Acta; 2014; 1839(4):297-305. PubMed ID: 24583551
[TBL] [Abstract][Full Text] [Related]
28. The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA.
Wang M; Gartel AL
Oncotarget; 2011 Dec; 2(12):1218-26. PubMed ID: 22203467
[TBL] [Abstract][Full Text] [Related]
29. Silibinin-induced glioma cell apoptosis by PI3K-mediated but Akt-independent downregulation of FoxM1 expression.
Zhang M; Liu Y; Gao Y; Li S
Eur J Pharmacol; 2015 Oct; 765():346-54. PubMed ID: 26342429
[TBL] [Abstract][Full Text] [Related]
30. Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line.
Maekawa A; Kohashi K; Setsu N; Kuda M; Iura K; Ishii T; Matsunobu T; Nakatsura T; Iwamoto Y; Oda Y
Cancer Sci; 2016 Jan; 107(1):95-102. PubMed ID: 26560505
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer.
Yang C; Chen H; Yu L; Shan L; Xie L; Hu J; Chen T; Tan Y
Cancer Gene Ther; 2013 Feb; 20(2):117-24. PubMed ID: 23306612
[TBL] [Abstract][Full Text] [Related]
32. TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1.
Zheng S; Zhou C; Wang Y; Li H; Sun Y; Shen Z
J Exp Clin Cancer Res; 2020 Jan; 39(1):23. PubMed ID: 31992359
[TBL] [Abstract][Full Text] [Related]
33. FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.
Li X; Yao R; Yue L; Qiu W; Qi W; Liu S; Yao Y; Liang J
J Cell Mol Med; 2014 May; 18(5):811-23. PubMed ID: 24628949
[TBL] [Abstract][Full Text] [Related]
34. FoxM1 inhibitors as potential anticancer drugs.
Gartel AL
Expert Opin Ther Targets; 2008 Jun; 12(6):663-5. PubMed ID: 18479213
[TBL] [Abstract][Full Text] [Related]
35. Thiostrepton confers protection against reactive oxygen species-related apoptosis by restraining FOXM1-triggerred development of gastric cancer.
Liu SX; Zhou Y; Zhao L; Zhou LS; Sun J; Liu GJ; Du YS; Zhou YN
Free Radic Biol Med; 2022 Nov; 193(Pt 1):385-404. PubMed ID: 36152915
[TBL] [Abstract][Full Text] [Related]
36. c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression.
Wang WD; Shang Y; Wang C; Ni J; Wang AM; Li GJ; Su L; Chen SZ
Acta Pharmacol Sin; 2022 Nov; 43(11):2956-2966. PubMed ID: 35422085
[TBL] [Abstract][Full Text] [Related]
37. FoxM1 as a novel therapeutic target for cancer drug therapy.
Xu XS; Miao RC; Wan Y; Zhang LQ; Qu K; Liu C
Asian Pac J Cancer Prev; 2015; 16(1):23-9. PubMed ID: 25640357
[TBL] [Abstract][Full Text] [Related]
38. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.
Calvisi DF; Pinna F; Ladu S; Pellegrino R; Simile MM; Frau M; De Miglio MR; Tomasi ML; Sanna V; Muroni MR; Feo F; Pascale RM
Gut; 2009 May; 58(5):679-87. PubMed ID: 19136513
[TBL] [Abstract][Full Text] [Related]
39. A novel peptide, 9R-P201, strongly inhibits the viability, proliferation and migration of liver cancer HepG2 cells and induces apoptosis by down-regulation of FoxM1 expression.
Bi Z; Liu W; Ding R; Wu Y; Dou R; Zhang W; Yuan X; Liu X; Xiong L; Guo Z; Mao C
Eur J Pharmacol; 2017 Feb; 796():175-189. PubMed ID: 28012972
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis induced by 7-difluoromethoxyl-5,4'-di-n-octyl genistein via the inactivation of FoxM1 in ovarian cancer cells.
Ning Y; Li Q; Xiang H; Liu F; Cao J
Oncol Rep; 2012 Jun; 27(6):1857-64. PubMed ID: 22447287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
